|
Movement Disorders
Citations 251-260 of 455 total displayed.
|
Past content
(since Jan 1998):
|
- Original Contributions
Analysis of the PINK1 Gene in a Large Cohort of Cases With Parkinson Disease
- Ekaterina Rogaeva; Janel Johnson; Anthony E. Lang; Cindy Gulick; Katrina Gwinn-Hardy; Toshitaka Kawarai; Christine Sato; Angharad Morgan; John Werner; Robert Nussbaum; Agnes Petit; Michael S. Okun; Aideen McInerney; Ronald Mandel; Justus L. Groen; Hubert H. Fernandez; Ron Postuma; Kelly D. Foote; Shabnam Salehi-Rad; Yan Liang; Sharon Reimsnider; Anurag Tandon; John Hardy; Peter St George-Hyslop; Andrew B. Singleton
Arch Neurol 2004; 61: 1898-1904.
[Abstract]
[Full text]
[PDF]
- Original Contributions
The Rate of Cognitive Decline in Parkinson Disease
- Dag Aarsland; Kjeld Andersen; Jan Petter Larsen; Robert Perry; Tore Wentzel-Larsen; Anette Lolk; Per Kragh-Sørensen
Arch Neurol 2004; 61: 1906-1911.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Lack of Regional Selectivity During the Progression of Parkinson Disease: Implications for Pathogenesis
- Chong S. Lee; Michael Schulzer; Raúl de la Fuente-Fernández; Edwin Mak; Lisa Kuramoto; Vesna Sossi; Thomas J. Ruth; Donald B. Calne; A. Jon Stoessl
Arch Neurol 2004; 61: 1920-1925.
[Abstract]
[Full text]
[PDF]
- Observations
Phenotypic and Molecular Analyses of X-linked Dystonia-Parkinsonism ("Lubag") in Women
- Virgilio Gerald H. Evidente; Dagmar Nolte; Stephan Niemann; Joel Advincula; Mezzanie C. Mayo; Filipinas F. Natividad; Ulrich Müller
Arch Neurol 2004; 61: 1956-1959.
[Abstract]
[Full text]
[PDF]
- Controversies in Neurology
Initial Treatment of Parkinson Disease: Levodopa or Dopamine Agonists
- William J. Weiner
Arch Neurol 2004; 61: 1966-1969.
[Extract]
[Full text]
[PDF]
- Controversies in Neurology
Dopamine Agonists Modify the Course of Parkinson Disease
- Matthew B. Stern
Arch Neurol 2004; 61: 1969-1971.
[Extract]
[Full text]
[PDF]
- Controversies in Neurology
Initial Parkinson Disease Therapy: Levodopa, Dopamine Agonists, or Both?
- E. S. Roach
Arch Neurol 2004; 61: 1972-1973.
[Extract]
[Full text]
[PDF]
- Original Contributions
Role of Dopaminergic Treatment in Dopamine Receptor Down-regulation in Advanced Parkinson Disease: A Positron Emission Tomographic Study
- Stéphane Thobois; François Vingerhoets; Valerie Fraix; Jing Xie-Brustolin; Hélène Mollion; Nicolas Costes; Patrick Mertens; Alim-Louis Benabid; Pierre Pollak; Emmanuel Broussolle
Arch Neurol 2004; 61: 1705-1709.
[Abstract]
[Full text]
[PDF]
- Observations
A Novel Polymerase  Mutation in a Family With Ophthalmoplegia, Neuropathy, and Parkinsonism
- Michelangelo Mancuso; Massimiliano Filosto; Shin J. Oh; Salvatore DiMauro
Arch Neurol 2004; 61: 1777-1779.
[Abstract]
[Full text]
[PDF]
- Correspondence
Positive Potential of Fetal Nigral Implants for Parkinson Disease
- William M. Landau
Arch Neurol 2004; 61: 1808-a-1809-a.
[Extract]
[Full text]
[PDF]
|
|
